Literature DB >> 11952051

Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy.

Hideo Kurihara1.   

Abstract

Total thyroidectomy was performed in 54 cases of Graves' ophthalmopathy from 1971 to August 2000. There were no surgical complications except for one case of mild hypocalcemia. The patients' postoperative lives were not disturbed. Ocular symptoms and signs were much improved after total thyroidectomy in most cases, but the ocular protrusion was reduced 0.9 mm on average (from 20.6 to 19.7 mm), and this improvement was not statistically significant. However, removal of the thyroid tissue was not complete in some cases in this series and the residual thyroid tissue may continuously support the progress of ophthalmopathy. Surgical influences on Graves' ophthalmopathy were compared between total and subtotal thyroidectomy in each of 50 gender- and age-matched cases from the same period. Average protrusion was reduced 0.9 mm after total thyroidectomy, but was increased 0.5 mm after subtotal thyroidectomy. In conclusion, total thyroidectomy can be performed as safely as subtotal thyroidectomy and is more effective for Graves' ophthalmopathy than subtotal thyroidectomy. However, this procedure would not be expected to completely inactivate aggressive ophthalmopathy, even if all thyroid tissue was removed. In severe cases, orbital decompression, corrective eye muscle, and lid surgery are necessary.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952051     DOI: 10.1089/105072502753600250

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  5 in total

1.  Long-term outcome of Graves' disease patients treated in a region with iodine deficiency: relapse rate increases in years with thionamides.

Authors:  Neslihan Basçil Tütüncü; Tanju Tütüncü; Ali Ozgen; Tomris Erbas
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

2.  Exacerbation of thyroid associated ophthalmopathy after arterial embolization therapy in a patient with Graves' disease.

Authors:  Tetsuya Hiraiwa; Akihisa Imagawa; Kazuhiro Yamamoto; Hiroshi Arimoto; Takeshi Arishima; Mitsuru Ito; Yasushi Nakamura; Fumio Matsuzuka; Akira Miyauchi; Jun Sugasawa; Tsunehiko Ikeda; Yoshifumi Narumi; Toshiaki Hanafusa
Journal:  Endocrine       Date:  2009-04-18       Impact factor: 3.633

3.  Near total thyroidectomy is an optimal treatment for graves' disease.

Authors:  Antoine Digonnet; Esther Willemse; Cécile Dekeyser; Luc Vandevelde; Moreau Michel; Daniel Glinoer; Denis Larsimont; Guy Andry
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-25       Impact factor: 2.503

4.  Total thyroidectomy as a method of choice in the treatment of Graves' disease - analysis of 1432 patients.

Authors:  Toplica Bojic; Ivan Paunovic; Aleksandar Diklic; Vladan Zivaljevic; Goran Zoric; Nevena Kalezic; Vera Sabljak; Nikola Slijepcevic; Katarina Tausanovic; Nebojsa Djordjevic; Dragana Budjevac; Lidija Djordjevic; Aleksandar Karanikolic
Journal:  BMC Surg       Date:  2015-04-09       Impact factor: 2.102

Review 5.  Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review.

Authors:  Thayalini Shanmuganathan; Christian Girgis; Hooshang Lahooti; Bernard Champion; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2015-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.